Women with a prior diagnosis of breast cancer are not at an increased risk for subsequent colorectal cancer

American Journal of Gastroenterology

Volumn 100, Issue 12, 2005, Pages 2759-2764

  Srinivasan, Radhika ^a   Yang, Yu Xiao ^a   Rubin, Stephen C ^a   Morgan, Mark A ^a   Lewis, James D ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b 720 Blockely Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; DATA BASE; FOLLOW UP; GENERAL PRACTITIONER RESEARCH DATABASE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; UNITED KINGDOM; AGE DISTRIBUTION; BREAST TUMOR; CASE CONTROL STUDY; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL TUMOR; COMPARATIVE STUDY; CONFIDENCE INTERVAL; FEMALE; INCIDENCE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POISSON DISTRIBUTION; PROGNOSIS; REFERENCE VALUE; RISK ASSESSMENT; SECOND CANCER;

ADULT; AGE DISTRIBUTION; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; POISSON DISTRIBUTION; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 33644821496     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.00316.x     Document Type: Article

References (37)

1. Jemal A Murray T Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003 53 ( 1 5 26.
2. Eisen GM Sandler RS. Are women with breast cancer more likely to develop colorectal cancer? Critical review and meta-analysis. J Clin Gastroenterol 1994 19 ( 1 57 63.
3. Schoen RE Weissfeld JL Kuller LH. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer? Am J Gastroenterol 1994 89 ( 6 835 42.
4. Newschaffer CJ Topham A Herzberg T, et al. Risk of colorectal cancer after breast cancer. Lancet 2001 357 ( 9259 837 40.
5. Kmet LM Cook LS Weiss NS, et al. Risk factors for colorectal cancer following breast cancer. Breast Cancer Res Treat 2003 79 ( 2 143 7.
6. Martinez ME Grodstein F Giovannucci E, et al. A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 1997 6 ( 1 1 5.
7. Yang YX Hennessy S Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 1044 127 ( 4 1044 50.
8. Yang YX Hennessy S Lewis JD. Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol 2005 3 : 587 94.
9. Bergstrom A Pisani P Tenet V, et al. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001 91 ( 3 421 30.
10. Hu FB Manson JE Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women (see comment). J Natl Cancer Inst 1999 91 ( 6 542 7.
11. Walley T Mantgani A. The UK General Practice Research Database. Lancet 1997 350 ( 9084 1097 9.
12. Garcia Rodriguez LA Perez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998 45 ( 5 419 25.
13. Hollowell J. The General Practice Research Database: Quality of morbidity data. Popul Trends 1997 ( 87 36 40.
14. Jick H Jick SS Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991 302 ( 6779 766 8.
15. Jick H Terris B Derby L, et al. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992 1 : 347 9.
16. Garcia-Rodriguez LA Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 2001 12 ( 1 88 93.
17. Yang YX Hennessy S Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004 127 ( 4 1044 50.
18. Kaye JA Derby LE del Mar Melero-Montes M, et al. The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data. Br J Cancer 2000 83 ( 11 1556 8.
19. Meier CR Derby LE Jick SS, et al. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med 2000 160 ( 3 349 53.
20. Lewis JD Bilker WB Weinstein R, et al. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 2005 14 : 443 51.
21. Mickey RM Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989 129 ( 1 125 37.
22. Morabia A Costanza MC. International variability in ages at menarche, first livebirth, and menopause. World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Am J Epidemiol 1998 148 ( 12 1195 205.
23. Fisher B Costantino JP Wickerham DL, et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998 90 ( 18 1371 88.
24. Curtis RE Boice JD Jr. Shriner DA, et al. Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst 1996 88 ( 12 832 4.
25. Cook LS Weiss NS Pharris-Ciurej N, et al. Colorectal cancer following tamoxifen therapy for breast cancer (United States). Cancer Causes Control 2001 12 ( 5 405 10.
26. Newcomb PA Solomon C White E. Tamoxifen and risk of large bowel cancer in women with breast cancer. Breast Cancer Res Treat 1999 53 ( 3 271 7.
27. Rutqvist LE Johansson H Signomklao T, et al. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst 1995 87 ( 9 645 51.
28. Jick H Jick S Derby LE, et al. Calcium-channel blockers and risk of cancer. Lancet 1997 349 ( 9051 525 8.
29. Mayor S. England to start national bowel cancer screening programme. BMJ 2004 329 ( 7474 6.
30. Mandel JS Church TR Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000 343 ( 22 1603 7.
31. Newcomb PA Storer BE Morimoto LM, et al. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 2003 95 ( 8 622 5.
32. Selby JV Friedman GD Quesenberry CP Jr., et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992 326 ( 10 653 7.
33. Winawer S Zauber A Ho N, et al. Prevention of colorectal cancer by polypectomy. N Engl J Med 1993 329 ( 27 1977 81.
34. Stotter A Bright N Silcocks PB, et al. Effect of improved data collection on breast cancer incidence and survival: Reconciliation of a registry with a clinical database. BMJ 2000 321 ( 7255 22.
35. Anonymous. Guidelines for colorectal cancer screening and surveillance. Gastrointest Endosc 2000 51 ( 6 777 82.
36. Winawer S Fletcher R Rex D, et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale - Update based on new evidence. Gastroenterology 2003 124 ( 2 544 60.
37. Rex DK Johnson DA Lieberman DA, et al. Colorectal cancer prevention 2000: Screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol 2000 95 ( 4 868 77.